U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H25N3O3
Molecular Weight 367.4415
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SORAPRAZAN

SMILES

COCCO[C@H]1[C@H](O)[C@H](NC2=C1C=CN3C(C)=C(C)N=C23)C4=CC=CC=C4

InChI

InChIKey=PWILYDZRJORZDR-MISYRCLQSA-N
InChI=1S/C21H25N3O3/c1-13-14(2)24-10-9-16-18(21(24)22-13)23-17(15-7-5-4-6-8-15)19(25)20(16)27-12-11-26-3/h4-10,17,19-20,23,25H,11-12H2,1-3H3/t17-,19-,20-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H25N3O3
Molecular Weight 367.4415
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:19:37 UTC 2023
Edited
by admin
on Sat Dec 16 17:19:37 UTC 2023
Record UNII
5XB3671655
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SORAPRAZAN
INN   WHO-DD  
INN  
Official Name English
Soraprazan [WHO-DD]
Common Name English
soraprazan [INN]
Common Name English
(7R,8R,9R)-7-(2-METHOXYETHOXY)-2,3-DIMETHYL-9-PHENYL-7,8,9,10-TETRAHYDROIMIDAZO(1,2-H)(1,7)NAPHTYRIDIN-8-OL
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29723
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
EU-Orphan Drug EU/3/13/1208
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
FDA ORPHAN DRUG 617617
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C87388
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
SMS_ID
100000089238
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
PUBCHEM
213054
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
EVMPD
SUB25228
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
MESH
C521310
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
ChEMBL
CHEMBL2105502
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
CAS
261944-46-1
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
FDA UNII
5XB3671655
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
INN
8188
Created by admin on Sat Dec 16 17:19:37 UTC 2023 , Edited by admin on Sat Dec 16 17:19:37 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
major component of lipofuschin. Promotes clearance of lopfuschin
TARGET -> INHIBITOR
REVERSIBLE
Ki
Related Record Type Details
ACTIVE MOIETY